Burlingame, CA, United States of America

Veena Krishnamoorthy


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Veena Krishnamoorthy: Pioneering Antibodies for Cancer Treatment

Introduction

Veena Krishnamoorthy is an accomplished inventor based in Burlingame, California. With a focus on medical innovations, she has made significant strides in the development of antibodies that target FLT3, a vital Fms-Like Tyrosine Kinase that plays a role in various pathologies, including cancer. Her groundbreaking work contributes to the ongoing battle against diseases such as Acute Myeloid Leukemia (AML).

Latest Patents

Veena holds two notable patents that showcase her expertise in antibody development. Her latest invention provides antibodies that specifically bind to FLT3. This remarkable innovation includes the creation of bispecific antibodies that can target both FLT3 and another antigen, such as CD3. Additionally, her patent covers antibody-encoding nucleic acids and the methodologies for obtaining these antibodies, both monospecific and bispecific. These therapies promise significant advancements in treating FLT3-mediated conditions, including specific cancers.

Career Highlights

Currently, Veena is associated with Pfizer Corporation, a leading company in the pharmaceutical sector. Her role involves conducting research and applying her expertise to develop innovative treatments that can improve patient outcomes. Veena's work reflects her commitment to enhancing healthcare through scientific innovation.

Collaborations

Throughout her career, Veena has had the opportunity to collaborate with talented colleagues such as Danielle Elizabeth Dettling and Yik Andy Yeung. These partnerships have enabled her to broaden her research capabilities and contribute to groundbreaking projects in the field of biotechnology.

Conclusion

Veena Krishnamoorthy stands out as an influential inventor in the realm of cancer therapeutics. Her patented innovations in antibody technology represent a beacon of hope for patients affected by FLT3-mediated diseases. As she continues to push the boundaries of science and medicine, her contributions will undoubtedly leave a lasting impact on the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…